These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36420189)

  • 1. Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply?
    Hara JHL; Jutzy JMS; Arya R; Kothari R; McCall AR; Howard AR; Hasan Y; Cursio JF; Son CH
    Adv Radiat Oncol; 2022; 7(6):100998. PubMed ID: 36420189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
    Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
    Kumar T; Schernberg A; Busato F; Laurans M; Fumagalli I; Dumas I; Deutsch E; Haie-Meder C; Chargari C
    Cancer Manag Res; 2019; 11():6285-6297. PubMed ID: 31372035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Rapid arc-based Radiation Therapy on Dosimetric Parameters in Cervical Cancer Patients with and without Bone Marrow Sparing.
    Aggarwal R; Sood S; Singh M; Singh K; Sood D; Mupasana V; Palanisamy M
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2407-2413. PubMed ID: 35901348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.
    Yang TJ; Oh JH; Apte A; Son CH; Deasy JO; Goodman KA
    Radiother Oncol; 2014 Oct; 113(1):29-34. PubMed ID: 25304718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
    Lewis S; Chopra S; Naga P; Pant S; Dandpani E; Bharadwaj N; Mahantshetty U; Engineer R; Swamidas J; Ghosh J; Gupta S; Shrivastava S
    Br J Radiol; 2018 Dec; 91(1092):20180005. PubMed ID: 30179056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Mell LK; Schomas DA; Salama JK; Devisetty K; Aydogan B; Miller RC; Jani AB; Kindler HL; Mundt AJ; Roeske JC; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1431-7. PubMed ID: 17996390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
    Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy.
    Lee J; Lin JB; Sun FJ; Lu KW; Lee CH; Chen YJ; Huang WC; Liu HC; Wu MH
    Br J Radiol; 2016 Oct; 89(1066):20160350. PubMed ID: 27556422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.
    Wang J; Tian Y; Tang Y; Wang X; Li N; Ren H; Fang H; Feng Y; Wang S; Song Y; Liu Y; Wang W; Li Y; Jin J
    Onco Targets Ther; 2016; 9():2701-7. PubMed ID: 27217780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Rose BS; Aydogan B; Liang Y; Yeginer M; Hasselle MD; Dandekar V; Bafana R; Yashar CM; Mundt AJ; Roeske JC; Mell LK
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):800-7. PubMed ID: 20400238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.
    Erpolat OP; Alco G; Caglar HB; Igdem S; Saran A; Dagoglu N; Aslay I; Ozsaran Z; Demirci S; Keven E; Guney Y; Akmansu M; Kilic D; Bayman E; Etiz D; Mandel NM
    Eur J Gynaecol Oncol; 2014; 35(1):62-6. PubMed ID: 24654465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review.
    Corbeau A; Kuipers SC; de Boer SM; Horeweg N; Hoogeman MS; Godart J; Nout RA
    Radiother Oncol; 2021 Nov; 164():128-137. PubMed ID: 34560187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Deek MP; Benenati B; Kim S; Chen T; Ahmed I; Zou W; Aisner J; Jabbour SK
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):147-154. PubMed ID: 26700708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.
    Franco P; Ragona R; Arcadipane F; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
    Clin Transl Oncol; 2017 Jan; 19(1):67-75. PubMed ID: 27037814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radiotherapy time and dose on acute hematologic toxicity during concurrent postoperative chemoradiotherapy for early high-risk cervical cancer.
    Yang X; Li Z; Zhang L; Li H; Yang X; Sun Y; Liu L; Fu J
    J Cancer; 2023; 14(6):895-902. PubMed ID: 37151393
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of irradiated bone marrow volume and neutropenia in patients undergoing concurrent chemoradiation therapy for cervical cancer.
    Antony F; Chalissery JR; Varghese KM; Gopu GP; Boban M
    J Cancer Res Ther; 2022; 18(6):1498-1503. PubMed ID: 36412400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.